by Holly Wobma | Nov 24, 2014
> For anyone who follows crime dramas, you’ve probably come across the token episode where the resident computer genius pulls up a double helix to unravel some genetic clue about an elusive villain. Of course, most people know that the information in DNA requires...
by Lisa Willemse | Nov 21, 2014
> This is a rather exciting time to be in the stem cell and regenerative medicine field and one of the main reasons for this is the number of announcements and articles about clinical trials taking place. Seven years ago, when I joined the Stem Cell Network, these...
by Mark Curtis | Nov 20, 2014
. You have all by now heard that Dendreon has filed for bankruptcy protection. If you’re a regular reader of Signals, you may have first heard the news here. While the company has successfully reached agreements on a financial restructuring with a majority of its...
by David Brindley | Nov 19, 2014
. With contributions from James Smith, a recent Oxford University graduate and current CASMI Translational Stem Cell Consortium Research Associate. Both the IBC Cell Therapy Bioprocessing (ICTB) conference and the Stem Cells and Regenerative Medicine Congress...
by Stacey Johnson | Nov 14, 2014
. The month of November can mean different things to different people. For example, Canadians recognize Remembrance Day on November 11, Americans have Veterans Day and my Polish friends celebrate National Independence Day. There’s American Thanksgiving immediately...
by David Brindley | Nov 13, 2014
. With contributions from James Smith, a recent Oxford University graduate and current CASMI Translational Stem Cell Consortium Research Associate In the early 1770s, Britain faced a significant financial dilemma. One of its most important commercial institutions,...
by Mark Curtis | Nov 10, 2014
. I had the pleasure of meeting Dr. Eytan Abraham over lunch on the first day of the Till & McCulloch Meetings, held last month in Ottawa (October 27-29). After some discussion about cell therapy manufacturing, I learned that he is the new Head of Research and...
by Ben Paylor | Nov 7, 2014
> The well known expression that “the eyes are the gateway to the soul” has tragic connotations in the context of retinal disease. Rhetoric aside, the potential for regenerative medicine to improve our ability to treat ocular disease and injury makes it an exciting...
by Mark Curtis | Nov 4, 2014
. Those following the regenerative medicine (RM) industry are likely in-tune with a rapidly evolving market, on the periphery, that is shaping up to provide a very attractive value proposition to patients, industry, and investors alike. The health care industry is...
by Stacey Johnson | Oct 31, 2014
. Hobgoblins, hocus pocus, hayrides and haunted houses…Happy Halloween! Do those words conjure up a feeling of dread or does a wave of happiness wash over you when you hear Happy Halloween? Perhaps more relevant here, does the word Halloween ever make you think of...
Comments